Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Januar 2018

Planlagt Fastgjort Låst Flyttet Genmab
2.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • SolsenS Offline
    SolsenS Offline
    Solsen
    wrote on sidst redigeret af
    #707

    Link Preview Image
    Th1/17 hybrid T cells offer potent and durable anti-tumor response in preclinical model

    Adoptive cell therapy for cancer involves harvesting T cells from a patient and expanding and sometimes modifying them in the laboratory before reinfusion. It has been challenging to create T cells that are both potent and durable. In a new study, researchers report the potent anti-tumor properties of hybrid Th1/Th17 cells that combine the cancer-fighting properties of Th1 cells and the ability of Th17 cells to self-renew and regenerate.

    favicon

    ScienceDaily (www.sciencedaily.com)

    1 Reply Last reply
    0
    • MumtazM Offline
      MumtazM Offline
      Mumtaz
      wrote on sidst redigeret af
      #708

      JKY jeg har ikke taget turen ned fra 1400 iden - kun i vestas - min snit i genmab er lavere end dagens kurs modsat vestas hvor klarsyn er sløret ;--)

      1 Reply Last reply
      0
      • J Offline
        J Offline
        JKY_VH
        wrote on sidst redigeret af
        #709

        ja, verden er jo ikke perfekt:-)

        1 Reply Last reply
        0
        • SolsenS Offline
          SolsenS Offline
          Solsen
          wrote on sidst redigeret af
          #710

          "We've known about NAD+ for almost 100 years, so, for me, the best part was when we realized that this intrinsic factor was responsible for the cells' strength," says Mehrotra. "That we could pick out one molecule, CD38, and produce this robust anti-tumor phenotype just by knocking it down was a big surprise. I actually thought that it wouldn't work-that we wouldn't get robust tumor control with the CD38 knockout cells. But it turns out that its ability to regulate the important cofactor NAD+ is

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #711

            Hvad får du ud af det Solsen? Det lyder som noget car-t-agtigt, hvor man udtager t-celler fra pt og laver en hybrid, som virker bedre, hvis cd38 bliver blokeret.

            1 Reply Last reply
            0
            • SolsenS Offline
              SolsenS Offline
              Solsen
              wrote on sidst redigeret af
              #712

              But it turns out that its ability to regulate the important cofactor NAD+ is so vital, that just by inhibiting it we could make the T cells work better."

              1 Reply Last reply
              0
              • SolsenS Offline
                SolsenS Offline
                Solsen
                wrote on sidst redigeret af
                #713

                Jeg håbede at du kunne vurdere det 🙂

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #714

                  Men det viser ihvert tilfælde at dara kan være "magic bullet"

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #715

                    ja, eller et andet cd38 antistof

                    1 Reply Last reply
                    0
                    • SolsenS Offline
                      SolsenS Offline
                      Solsen
                      wrote on sidst redigeret af
                      #716

                      Jo. Men nu vil dara jo være kendt og derfor have en god mulighed, hvis der er noget i dette.

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #717

                        I hvert fald vil der være et problem med ventetiden. Ved ACT udtager man T-celler og kultiverer dem i uger eller mdr. Og i mellemtiden dør så patienten. Skeptikere ved car-t har netop peget på dette problem ved t-celle transplantationer i det hele taget.

                        1 Reply Last reply
                        0
                        • SolsenS Offline
                          SolsenS Offline
                          Solsen
                          wrote on sidst redigeret af
                          #718

                          Pointen er jo at cd38 spiller en central rolle for T-cellerne. Det hvad enten det er ACT eller "in natura"

                          1 Reply Last reply
                          0
                          • SolsenS Offline
                            SolsenS Offline
                            Solsen
                            wrote on sidst redigeret af
                            #719

                            Endnu et bevis på at dara kan noget udenfor mm.

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #720

                              Dara kan noget overalt - bare der er cd38 til stede. Og hvis der ikke er, så har vi SY-1425, der kan skaffe det. 😉

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                pauly
                                wrote on sidst redigeret af
                                #721

                                nogen samler i alt fald aktierne op så de har set en god mulighed

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  pauly
                                  wrote on sidst redigeret af
                                  #722

                                  Det tænker jeg ikke det er, men alt er vel muligt i dette spil. Det lyder heller ikke som en lovlig tilgang, men det er nok uden betydning. Reglerne gælder jo kun for private 😄

                                  1 Reply Last reply
                                  0
                                  • bongobobB Offline
                                    bongobobB Offline
                                    bongobob
                                    wrote on sidst redigeret af
                                    #723

                                    God morgen. En hurtig google viser der er en forbindelse " AHL Partners LLP lifted its stake in Artisan Partners Asset Management by 102.3% during the second quarter. AHL Partners LLP now owns 226,766 shares of the asset manager’s stock worth $6,962,000 after purchasing an additional 114,696 shares during the last quarter"

                                    1 Reply Last reply
                                    0
                                    • bongobobB Offline
                                      bongobobB Offline
                                      bongobob
                                      wrote on sidst redigeret af
                                      #724

                                      Lad spekulationerne begynde

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        pauly
                                        wrote on sidst redigeret af
                                        #725

                                        godt set af pensionisten

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #726

                                          God morgen. 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger